Cramer’s lightning round: Not recommending Nio or any Chinese stocks

Business

Veru: “Veru is in [Phase 3] for a very important breast cancer indication. They just got fast-track designation by the FDA this morning. It’s at $5. It made no sense that the stock didn’t go up to me. I thought it should’ve been up on the news.”

Nio: “Nope. Not recommending that. Not recommending any of the Chinese stocks. In particular, I don’t like that stock. I just feel like there are people who want to speculate all the time on China. This is a different kind of China than what we’re used to. It is a communist country that does not seem to favor capitalist development anymore.”

Grab Holdings: “We thought that was interesting when we looked at it. We like it. It’s got much more than just Uber. … I like the stock. I like it. We liked it when we looked at it.”

International Paper: “Cheap stock, but always a cheap stock. I don’t want a stock that’s always a cheap stock. I want a stock that moves higher.”

SMART Global Holdings: “I’ve got to relook at it because this is involving smart phones, and smart phones are under pressure here.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Products You May Like

Articles You May Like

BP posts record 2022 earnings to join Big Oil profit bonanza
Before you enroll in Medicare, what to know about new rules that eliminate coverage gaps
Roughly 70% of taxpayers are eligible for IRS Free File, but only 2% used it in 2022
Ferrari’s profits jump 13% in 2022, supercar maker expects an even better year in 2023
Biden administration expands EV tax credits in boost for Tesla, Cadillac, others

Leave a Reply

Your email address will not be published. Required fields are marked *